Nanoscale drug delivery systems and the blood–brain barrier
Renad Alyautdin,1 Igor Khalin,2 Mohd Ismail Nafeeza,1 Muhammad Huzaimi Haron,1 Dmitry Kuznetsov31Faculty of Medicine, Universiti Teknologi MARA (UiTM), Sungai Buloh, Selangor, Malaysia; 2Faculty of Medicine and Defence Health, National Defence University of Malaysia (NDUM), Kuala Lumpur, Malaysia;...
Guardado en:
Autores principales: | Alyautdin R, Khalin I, Nafeeza MI, Haron MH, Kuznetsov D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5cb3eb8d64074d22941bf91763dd87de |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness
por: Khalin I, et al.
Publicado: (2015) -
Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier
por: Vieira DB, et al.
Publicado: (2016) -
Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours
por: Ferraris C, et al.
Publicado: (2020) -
Efficiency of drug delivery enhanced by acoustic pressure during blood–brain barrier disruption induced by focused ultrasound
por: Yang FY, et al.
Publicado: (2012) -
Optimizing superparamagnetic iron oxide nanoparticles as drug carriers using an in vitro blood–brain barrier model
por: Shi D, et al.
Publicado: (2016)